NGeneBio Co

NGeneBio Co EBIT per Share

The EBIT per Share of NGeneBio Co (354200.KQ) as of Oct 3, 2026 is -834.49 KRW. In the previous year, EBIT per Share was -714.21 KRW — a change of 16.84% (lower).

EBIT per Share

-834.49KRW

YoY

16.84%

Last updated:

EBIT per Share of NGeneBio Co is 2026 -834.49 KRW. EBIT per Share of NGeneBio Co was 2025 -714.21 KRW. It decreases by 16.84% lower compared to the previous year.

The NGeneBio Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-293.14 KRW
Jan 1, 2019
-356.38 KRW
Jan 1, 2020
-499.69 KRW
Jan 1, 2021
-688.39 KRW
Jan 1, 2022
-689.43 KRW
Jan 1, 2023
-1,048.70 KRW
Jan 1, 2024
-714.21 KRW
Jan 1, 2025
-834.49 KRW
The NGeneBio Co EBIT per Share history
YEAREBIT per ShareYoY
-834.49KRW+16.84%
-714.21KRW-31.90%
-1,048.70KRW+52.11%
-689.43KRW+0.15%
-688.39KRW+37.76%
-499.69KRW+40.21%
-356.38KRW+21.57%
-293.14KRW—
Access this data via the Eulerpool API
Get Free API Key

NGeneBio Co Stock analysis

What does NGeneBio Co do? NGeneBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NGeneBio Co stock

EBIT per Share of NGeneBio Co is -834.49 KRW in 2026.

EBIT per Share of NGeneBio Co changed from -714.21 KRW to -834.49 KRW, representing a 16.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share NGeneBio Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — NGeneBio Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — NGeneBio Co